The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hyperpigmentation


High impact information on Hyperpigmentation


Chemical compound and disease context of Hyperpigmentation


Biological context of Hyperpigmentation


Anatomical context of Hyperpigmentation


Gene context of Hyperpigmentation


Analytical, diagnostic and therapeutic context of Hyperpigmentation


  1. Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. Whitney, M., Thayer, M., Reifsteck, C., Olson, S., Smith, L., Jakobs, P.M., Leach, R., Naylor, S., Joenje, H., Grompe, M. Nat. Genet. (1995) [Pubmed]
  2. A syndrome of methylmalonic aciduria, homocystinuria, megaloblastic anemia and neurologic abnormalities in a vitamin B12-deficient breast-fed infant of a strict vegetarian. Higginbottom, M.C., Sweetman, L., Nyhan, W.L. N. Engl. J. Med. (1978) [Pubmed]
  3. Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germline mutation of the c-kit gene. Maeyama, H., Hidaka, E., Ota, H., Minami, S., Kajiyama, M., Kuraishi, A., Mori, H., Matsuda, Y., Wada, S., Sodeyama, H., Nakata, S., Kawamura, N., Hata, S., Watanabe, M., Iijima, Y., Katsuyama, T. Gastroenterology (2001) [Pubmed]
  4. Homozygosity for hemochromatosis: clinical manifestations. Edwards, C.Q., Cartwright, G.E., Skolnick, M.H., Amos, D.B. Ann. Intern. Med. (1980) [Pubmed]
  5. Complications of therapy in cancer patients: Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer. Chang, G.C., Yang, T.Y., Chen, K.C., Yin, M.C., Wang, R.C., Lin, Y.C. J. Clin. Oncol. (2004) [Pubmed]
  6. Tretinoin for hyperpigmentation in black patients. LaVoo, E.J. N. Engl. J. Med. (1993) [Pubmed]
  7. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. Bulengo-Ransby, S.M., Griffiths, C.E., Kimbrough-Green, C.K., Finkel, L.J., Hamilton, T.A., Ellis, C.N., Voorhees, J.J. N. Engl. J. Med. (1993) [Pubmed]
  8. Letter: Serpentine supravenous fluorouracil hyperpigmentation. Hrushesky, W.J. JAMA (1976) [Pubmed]
  9. Minocycline-induced oral hyperpigmentation. Eisen, D. Lancet (1997) [Pubmed]
  10. Melanocyte-stimulating-hormone levels in doxorubicin-induced hyperpigmentation. Kew, M.C., Mzamane, D., Smith, A.G., Shuster, S. Lancet (1977) [Pubmed]
  11. Clinical images: Hydroxychloroquine-associated mucocutaneous hyperpigmentation. True, D.G., Bryant, L.R., Harris, M.D., Bernert, R.A. Arthritis Rheum. (2002) [Pubmed]
  12. Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. Kim, Y.M., Yun, J., Lee, C.K., Lee, H., Min, K.R., Kim, Y. J. Biol. Chem. (2002) [Pubmed]
  13. Nail, hair and skin hyperpigmentation associated with indinavir therapy. Terheggen, F., Frissen, J., Weigel, H., Schouten, I., Brinkman, K. AIDS (2004) [Pubmed]
  14. Genetic heterogeneity in Peutz-Jeghers syndrome. Boardman, L.A., Couch, F.J., Burgart, L.J., Schwartz, D., Berry, R., McDonnell, S.K., Schaid, D.J., Hartmann, L.C., Schroeder, J.J., Stratakis, C.A., Thibodeau, S.N. Hum. Mutat. (2000) [Pubmed]
  15. Clinical, genetic, and functional characterization of adrenocorticotropin receptor mutations using a novel receptor assay. Flück, C.E., Martens, J.W., Conte, F.A., Miller, W.L. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  16. Purification and characterization of an allergy-induced melanogenic stimulating factor in brownish guinea pig skin. Imokawa, G., Higuchi, K., Yada, Y. J. Biol. Chem. (1998) [Pubmed]
  17. Inhibition of skin pigmentation by an extract of Lepidium apetalum and its possible implication in IL-6 mediated signaling. Choi, H., Ahn, S., Lee, B.G., Chang, I., Hwang, J.S. Pigment Cell Res. (2005) [Pubmed]
  18. Minocycline hyperpigmentation isolated to the subcutaneous fat. Rahman, Z., Lazova, R., Antaya, R.J. J. Cutan. Pathol. (2005) [Pubmed]
  19. Biostimulation of dermal fibroblast by sublethal Q-switched Nd:YAG 532 nm laser: collagen remodeling and pigmentation. Poon, V.K., Huang, L., Burd, A. J. Photochem. Photobiol. B, Biol. (2005) [Pubmed]
  20. The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice. Atit, R.P., Mitchell, K., Nguyen, L., Warshawsky, D., Ratner, N. J. Invest. Dermatol. (2000) [Pubmed]
  21. Clinical pharmacokinetics of clofazimine. A review. Holdiness, M.R. Clinical pharmacokinetics. (1989) [Pubmed]
  22. Parapapillary chorioretinal atrophy in normal and glaucoma eyes. II. Correlations. Jonas, J.B., Naumann, G.O. Invest. Ophthalmol. Vis. Sci. (1989) [Pubmed]
  23. Latanoprost and hyperpigmentation of eyelashes. Wand, M. Arch. Ophthalmol. (1997) [Pubmed]
  24. Wandering fixed drug eruption: a mucocutaneous reaction to acetaminophen. Guin, J.D., Haynie, L.S., Jackson, D., Baker, G.F. J. Am. Acad. Dermatol. (1987) [Pubmed]
  25. Expression of prohormone convertase, PC2, in adrenocorticotropin-producing thymic carcinoid with elevated plasma corticotropin-releasing hormone. Kimura, N., Ishikawa, T., Sasaki, Y., Sasano, N., Onodera, K., Shimizu, Y., Kimura, I., Steiner, D.F., Nagura, H. J. Clin. Endocrinol. Metab. (1996) [Pubmed]
  26. The epidermal stem cell factor is over-expressed in lentigo senilis: implication for the mechanism of hyperpigmentation. Hattori, H., Kawashima, M., Ichikawa, Y., Imokawa, G. J. Invest. Dermatol. (2004) [Pubmed]
  27. Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss. Sharov, A.A., Li, G.Z., Palkina, T.N., Sharova, T.Y., Gilchrest, B.A., Botchkarev, V.A. J. Invest. Dermatol. (2003) [Pubmed]
  28. Adrenal insufficiency secondary to hypothalamic corticotropin releasing factor (CRF) insufficiency with hyperpigmentation: a case report. Fehm, H.L., Voigt, K.H., Lang, R., Hetzel, W.D., Pfeiffer, E.F. Horm. Metab. Res. (1976) [Pubmed]
  29. A study of patients with Nelson's syndrome. Pereira, M.A., Halpern, A., Salgado, L.R., Mendonça, B.B., Nery, M., Liberman, B., Streeten, D.H., Wajchenberg, B.L. Clin. Endocrinol. (Oxf) (1998) [Pubmed]
  30. Flagellate hyperpigmentation following intralesional bleomycin treatment of verruca plantaris. Abess, A., Keel, D.M., Graham, B.S. Archives of dermatology. (2003) [Pubmed]
  31. Selective cutaneous hyperpigmentation in mice following zidovudine administration. Obuch, M.L., Baker, G., Roth, R.I., Yen, T.S., Levin, J., Berger, T.G. Archives of dermatology. (1992) [Pubmed]
  32. Tretinoin in the preoperative and postoperative management of dermabrasion. Mandy, S.H. J. Am. Acad. Dermatol. (1986) [Pubmed]
  33. Long-term clinical experience with a topical retinoid. Thorne, E.G. Br. J. Dermatol. (1992) [Pubmed]
WikiGenes - Universities